According to the May 2015 Newsletter there are phase 1B results due on the BNC210 drug this quarter. Mid 50's are possible in the build-up IMO and following positive results we'll be looking at breakout.
- Forums
- ASX - By Stock
- Ann: BNC101 FDA SUBMISSION SUCCESSFUL
According to the May 2015 Newsletter there are phase 1B results...
Featured News
Add BNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online